While researchers work hard to better diagnose and treat Alzheimer’s, typically “patients receive a diagnosis of Alzheimer’s only after they exhibit well-known signs of the disease, such as memory loss. By that point, the best treatment options simply slow further progression of symptoms.” However, researchers have developed a lab test to measure amyloid beta oligomers which are thought to develop into Alzheimer’s. This early detection could help prevent symptoms for many patients.